BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Angiogenesis
,
Breast Cancer
,
Retina
,
DNA fingerprint
,
Cisplatin
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LQT3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Heart
Heart ventricle
Heart atrium
Vena cava
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Conduction disorder of the heart
Death
Muscle atrophy
Steinert myotonic dystrophy syndrome
COVID-19
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
indecainide
Encainide
ethotoin
Flecainide
Mephenytoin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TWIST1
AK096729
CHMP2B
ELF3
MSX1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond.
The SCN5A Gene Is a Predictor of Phenotype Severity in Brugada Syndrome: A Comprehensive Literature …
Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
SCN5A overlap syndromes: An open-minded approach.
Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the ef…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy Study of Sodium Channel Blocker in LQT3 Patients
Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long …
Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diag…
Effect of Eleclazine on QT, Safety, and Tolerability in Adults With Long QT2 Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ